Month: May 2023

                         Share Buyback Transaction Details May 18 – May 24, 2023 May 25, 2023 – Wolters Kluwer (Euronext: WKL), a global leading provider of expert solutions, insights and services for professionals, today reports that it has repurchased 150,530 of its own ordinary shares in the period from May 18, 2023, up to and including May 24, 2023, for €16.3 million and at an average share price of €108.53. These repurchases are part of the share buyback program announced on February 22, 2023, under which we intend to repurchase shares for up to €1 billion during 2023. The cumulative amounts repurchased to date under this program are as follows: Share Buyback 2023Period Cumulative shares repurchased in period Total consideration(€ million) Average share price(€)2023 to date 3,221,709 352.0 109.25For the period starting...

Serstech has today received an order of 27.5 MSEK from its partner Proengin Inc in the USA. The order consists of hardware, software and the patented SERS kit and will be delivered and invoiced before the end of June 2023. The order is the second larger order within five months of the new Serstech Arx product. For further information, please contact:Stefan Sandor, CEO, Serstech AB Phone: +46 739 606 067 Email: ss@serstech.com Thomas Pileby, Chairman of the Board, Serstech AB Phone: +46 702 072 643 Email: tp@serstech.com or visit:  www.serstech.com This is information that Serstech AB (publ.) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above at 08:45 CET on May 25, 2023. Certified advisor to Serstech is Svensk Kapitalmarknadsgranskning...

Press release – MAY 25, 2023 Appointments at WendelAs part of Wendel’s new strategic directions, announced on March 16, Wendel’s Executive Board has decided to entrust Jérôme Michiels with the responsibility of structuring its third-party asset management activity. This new mission is added to his responsibilities as Executive Vice-President, in particular searching for new investment opportunities, monitoring certain direct portfolio companies, managing Wendel Growth and continuing to supervise Wendel’s financial communications team, whose organization remains unchanged. Following this change, Benoît Drillaud has been promoted to Chief Financial Officer of Wendel. Reporting to the Executive Board, he is responsible for managing the Finance and Accounting Department. These changes are effective as of today.Biography of...

Oslo, Norway, 25 May– IDEX Biometrics and SELP, a French card manufacturer and personalization center with a global footprint, are entering an agreement to scale the deployment of biometric smart cards, in response to growing demand for secure and convenient payment and identification solutions. With an annual card production of more than 350 million and servicing over 60 countries across Europe, Central America, Africa, the Middle East, and India, SELP is uniquely positioned to drive the commercialization of biometric technology across a wide range of sectors including payments, digital ID, digital services, and retail. “This agreement enables us to strengthen the ecosystem and meet the increasing demand for seamless payment and identification experiences,” said Bastien Blanc, General Manager of SELP. “By working with IDEX Biometrics,...

Mendus AB (“Mendus” publ; IMMU.ST), a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, today announced its participation in the following upcoming investor and industry conferences:Redeye Growth Day Virtual, June 1, 2023 Mendus CEO Erik Manting will participate in a live Q&A session on June 1st. Further details including the on-demand corporate presentation are available via:https://www.redeye.se/events/871323/redeye-growth-dayBIO International Convention Boston, USA, June 5-8, 2023 Erik Manting, CEO of Mendus, will attend the conference. https://www.bio.org/events/bio-international-conventionEHA2023 Hybrid Congress Frankfurt, Germany, and Virtual, June 8-11, 2023 Mendus to present updates on immunomonitoring data from ADVANCE II trial and progress on the development of its NK cell therapy program. https://ehaweb.org/congress/eha2023-hybrid-congress/eha2023/FOR...

Atari launches an offering of bonds convertible into new ordinary shares of Atari maturing in 2026 with a 6.50% coupon for a nominal amount of approximately 30 million eurosIssuance of bonds convertible into ordinary shares without shareholders’ preferential subscription rights, by way of a public offering and with a four-day priority subscription period, on an irreducible and reducible basis Public subscription period and priority subscription period: from May 25, 2023 to May 30, 2023 (included) at 5:00 p.m. (Paris time) Subscription price set at 0.15 euro per convertible bond Subscription commitment of Irata LLC to subscribe for 100% of the Offering Key financial information as of March 31, 2023PARIS, FRANCE (May 25, 2023 – 7:45 am CET) – Atari® (the “Company”) — one of the world’s most iconic...

Ecully, May 25th, 2023 PCAS to sell its Canadian subsidiary, PCAS Canada Inc., to DIC CorporationPCAS (Euronext Paris: PCA), specialized in the development of processes and production of complex molecules for Life Sciences and Specialty Chemicals Markets, has made the decision to sell PCAS Canada Inc., the Canadian subsidiary of PCAS Group, to DIC Corporation, a Japanese chemicals group with a presence in more than 60 countries. An enterprise value of 88.2 million euros has been agreed for PCAS Canada Inc. This decision has been made following the receipt of an offer from DIC Corporation for the acquisition of the Canadian subsidiary announced on May 2nd, 2023 (https://www.pcas.com/). This offer has been accepted by PCAS following the authorization of its Board of Directors. The competent workers’ council has been previously informed...

Letter to Shareholders and Corporate UpdateAccess to EUR15 million under amended deal Donesta® U.S. marketing deal is a key near term priority CDMO strategic options are being explored Donesta® filing rescheduled for H2 2023 – still expecting U.S. approval in H1 2024 Financial update and guidance providedLiege, Belgium, 25 May 2023 – 7:30 CEST – Mithra (Euronext Brussels: MITRA), a company dedicated to Women’s Health, (the “Company” or “Mithra”), today published a Corporate Update and Letter to Shareholders from recently appointed Chief Executive Officer, Dr. David Horn Solomon. Dear Fellow Shareholders, I am pleased to have joined Mithra as CEO on April 11th. I was made fully aware of the Company’s recent challenges and the many justified concerns of our shareholders. I accepted the role because my...

Letter to Shareholders and Corporate UpdateAccess to EUR15 million under amended deal Donesta® U.S. marketing deal is a key near term priority CDMO strategic options are being explored Donesta® filing rescheduled for H2 2023 – still expecting U.S. approval in H1 2024 Financial update and guidance providedLiege, Belgium, 25 May 2023 – 7:30 CEST – Mithra (Euronext Brussels: MITRA), a company dedicated to Women’s Health, (the “Company” or “Mithra”), today published a Corporate Update and Letter to Shareholders from recently appointed Chief Executive Officer, Dr. David Horn Solomon. Dear Fellow Shareholders, I am pleased to have joined Mithra as CEO on April 11th. I was made fully aware of the Company’s recent challenges and the many justified concerns of our shareholders. I accepted the role because my analysis...